Literature DB >> 25808650

The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease.

Guoxun Chen1.   

Abstract

The liver is essential for the control of glucose and lipid metabolism. Excessive accumulation of fat in the liver disturbs its function and leads to the development of fatty liver diseases. The nonalcoholic fatty liver disease (NAFLD) is a common type of fatty liver disease found in patients who have not consumed significant amount of alcohol. Multiple factors and cell types contribute to the development and progression of NAFLD. Diets contain macronutrients with energy and micronutrients with regulatory roles. As an essential micronutrient, vitamin A (VA), plays critical roles in various physiological functions including the regulation of glucose and lipid homeostasis in the liver. The body's VA is mainly stored in quiescent hepatic stellate cells (HSCs) in the liver. Hepatocytes actively metabolize VA, and change glucose and lipid metabolism in response to VA metabolites. Interestingly, the activated HSCs lose their VA content and contribute to the NAFLD progression. Significant number of studies have been conducted to investigate the link between VA metabolism and NAFLD development. This review is to summarize current literatures that discuss the changes of VA metabolism occurring locally between hepatocytes and HSCs, and intracellularly in hepatocytes during the course of NAFLD development. It appears that factors derived from HSCs and hepatocytes mutually affect each other, which contributes to NAFLD development. Additionally, this review discusses the potential mechanism by which excessive VA metabolism increases lipogenesis and contributes to fat accumulation in hepatocytes. It offers potential future directions for the study of the role of VA metabolism in the NAFLD development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808650     DOI: 10.2174/1389450116666150325231015

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  9 in total

1.  17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.

Authors:  Yanling Ma; Olga V Belyaeva; Philip M Brown; Koji Fujita; Katherine Valles; Suman Karki; Ynto S de Boer; Christopher Koh; Yanhua Chen; Xiaomeng Du; Samuel K Handelman; Vincent Chen; Elizabeth K Speliotes; Cara Nestlerode; Emmanuel Thomas; David E Kleiner; Joseph M Zmuda; Arun J Sanyal; Natalia Y Kedishvili; T Jake Liang; Yaron Rotman
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

Review 2.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

Review 3.  Hepatic Retinyl Ester Hydrolases and the Mobilization of Retinyl Ester Stores.

Authors:  Lukas Grumet; Ulrike Taschler; Achim Lass
Journal:  Nutrients       Date:  2016-12-27       Impact factor: 5.717

Review 4.  Hydrogen: An Endogenous Regulator of Liver Homeostasis.

Authors:  Yaxing Zhang; Jingting Xu; Hongzhi Yang
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

5.  HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease.

Authors:  Peter Ferenci; Jan Pfeiffenberger; Albert Friedrich Stättermayer; Rudolf E Stauber; Claudia Willheim; Karl H Weiss; Petra Munda-Steindl; Michael Trauner; Michael Schilsky; Heinz Zoller
Journal:  JHEP Rep       Date:  2019-03-19

6.  Spaceflight Activates Lipotoxic Pathways in Mouse Liver.

Authors:  Karen R Jonscher; Alba Alfonso-Garcia; Jeffrey L Suhalim; David J Orlicky; Eric O Potma; Virginia L Ferguson; Mary L Bouxsein; Ted A Bateman; Louis S Stodieck; Moshe Levi; Jacob E Friedman; Daila S Gridley; Michael J Pecaut
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

Review 7.  Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.

Authors:  Fang Yang; Guo-Xun Chen
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

Review 8.  The Role of Vitamin E in the Treatment of NAFLD.

Authors:  Brandon J Perumpail; Andrew A Li; Nimy John; Sandy Sallam; Neha D Shah; Waiyee Kwong; George Cholankeril; Donghee Kim; Aijaz Ahmed
Journal:  Diseases       Date:  2018-09-24

9.  Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status.

Authors:  Dongsub Jeon; Minkook Son; Juhyun Shim
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.